Delivery Order SPE2DB20D1100-SPE2DB23FC5G7

Award Date 7/12/23
Potential Completion Date 7/13/23
Potential Value $11K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $17,338 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. As the prime contractor, Amerisourcebergen will supply the biologic drug to the DLA under a one-day period of performance in Conshohocken, Pennsylvania. Amerisourcebergen Corporation is the parent company. No subcontractors or set aside designations were indicated. The DLA manages the global supply chain for the Department of Defense, procuring all...
The Defense Logistics Agency awarded a $28,787 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. As the prime contractor, Amerisourcebergen will supply the biologic drug to the DLA under a one-day period of performance in Conshohocken, Pennsylvania. Amerisourcebergen Corporation is the parent company. No subcontractors or set aside designations were indicated. The DLA manages the global supply chain for the Department of Defense, ensuring...
The Defense Logistics Agency awarded a $10,044.82 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Under this contract, Amerisourcebergen will provide approximately two pens of the drug to fulfill DLA requirements. As the parent company of Amerisourcebergen Drug Corporation, Amerisourcebergen Corporation will perform the contract from its Conshohocken, Pennsylvania location. No major subcontractors or set aside designations were identified....
The Defense Logistics Agency awarded a $43,857.77 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the product to a location in Conshohocken, Pennsylvania by August 1, 2023 in support of DLA programs. No set aside designation or subcontractors were identified. DLA facilitates supply chain management for the Department of Defense, so this order for...
The Defense Logistics Agency awarded a $10,365.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Under this single award, Amerisourcebergen will deliver 2ML pens of DUPIXENT to a location in Conshohocken, Pennsylvania by August 31, 2023 to support Defense Logistics Agency programs. Amerisourcebergen Corporation is the identified parent company for Amerisourcebergen Drug Corporation, the prime contractor performing under this delivery order...
The Defense Logistics Agency awarded a $16,364 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. As the prime contractor, Amerisourcebergen will supply the biologic drug to the DLA under a one-day period of performance in Conshohocken, Pennsylvania. No subcontractors or set aside designations were specified. The DLA procures medical supplies and equipment for various DoD programs and stockpiles, so this order is likely supporting treatment for...
The Defense Logistics Agency awarded a $10,801 delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Under the terms of the firm fixed price contract, Amerisourcebergen will provide the specified pharmaceutical product to the DLA by September 8, 2023 from its facility in Conshohocken, Pennsylvania. As a leading provider of medical supplies to the Department of Defense, the DLA relies on contracts such as these with major distributors including Amerisourcebergen...
The Defense Logistics Agency awarded a $11,677.77 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. The contract calls for Amerisourcebergen to provide 2ML pens of the drug to support DLA's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of 3 days from August 18th through the 21st of 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug...
The Defense Logistics Agency awarded a $35,472.10 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Under this single award, Amerisourcebergen will provide approximately 2,000 pens of the injectable drug to support DLA's medical supply needs. As the prime, Amerisourcebergen will perform the order itself out of its Conshohocken, Pennsylvania distribution facility. No subcontractors or set aside designations were specified. This award is...
The Defense Logistics Agency awarded a $23,511 delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. As the prime contractor, Amerisourcebergen will supply the biologic drug to the DLA under a firm fixed price contract set to be completed within two days in September 2023. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania with no subcontractors involved. The DLA manages the Department of Defense's supplies including...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB23FC5G7
    Delivery Order

The Defense Logistics Agency awarded a $11,220 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. As the prime contractor, Amerisourcebergen will supply the biologic drug to the DLA under a one-day period of performance in Conshohocken, Pennsylvania. Amerisourcebergen Corporation is the parent company. No subcontractors or set aside designations were indicated. The DLA manages the global supply chain for the Department of Defense, ensuring critical medical supplies and treatments are available for military personnel worldwide. This award supports the agency's mission by providing an important therapeutic for conditions like atopic dermatitis.

Generated 12/20/23, 1:35 AM